(11) 98705-3426
TrademarkIQ íconeTrademarkIQ
Voltar para busca
Dado oficial do USPTO

CORVISION

Sabia que essa marca já está registrada no Estados Unidos?

Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.

Active USPTO registrationTipo: VerbalEscritório: US

Snapshot rápido

CORVISION

ST13

US500000079286492

Classe

5, 10

Pedido

79286492

Registro

6495490

Diagnóstico de risco e oportunidade

Leitura executiva para decisão de naming, protocolo e monitoramento.

Atenção: há risco ativo

Situação USPTO

Active USPTO registration

Tipo de processo

Pedido e registro

Eventos registrados

38

Atualização mais recente

07/03/2025

Classificação

Registrada

Tipo de marca

Verbal

Classes Nice

5, 10

Data de depósito

31/01/2020

Data de registro

28/09/2021

Data de expiração

-

Ação recomendada

Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.

Próximo passo

Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.

Dados completos do processo

Campos estruturados da autoridade responsável e do histórico oficial.

Data da situação

28/09/2021

Última transação

07/03/2025

Escritório responsável

United States Patent and Trademark Office

Código da situação

700

Cadastro oficial

Principal Register

Código do desenho

4

Tipo de titular

64

Localização do titular

SE

Examinador

BILLINGS, JOHN

Unidade examinadora

M40

Localização atual

PUBLICATION AND ISSUE SECTION

Titulares e representantes

Titulares

LinkoCare Life Sciences AB

Representantes

R Peter Spies DTL Limited

Classificação técnica

Classes Nice

Classe 5Classe 10

Códigos Vienna

Sem códigos Vienna disponíveis.

Produtos e serviços

Classe 5

Collagen for medical use; biological implantsbiological eye tissue intended for subsequent implantationbiological skin tissue intended for subsequent implantationbiological cardiac tissue intended for subsequent implantationbiological tissue grafts; biological cornealcardiacnerveskin tissue for implantation; surgical implants comprised of living tissues; biological materials in the nature of biological preparation for the treatment of eye disease for medical purposes; bioengineered materials in the nature of biological eye tissue; bioengineered biological organ tissues for medicalveterinary and pharmaceutical purposes; biological implants comprising biopolymerscollagennanocelluloseliving tissue for delivery of stem cells and biological agents; implants comprising living tissue; implants comprising biopolymerscollagennanocellulose for guided tissue regeneration; surgical implants biopolymerscollagennanocellulose and native tissuegrown from stem cells; implantable materials in the nature of biopolymerscollagennanocellulosenative tissue for use in guided tissue regeneration; cell culture media for medical purposes for cultivating human and animal cells such as cornealcardiac cells and stem cells

Classe 10

Corneal implants in the form of inlays made of artificial and naturalnon-livingmaterials; corneal microlens for sight correction being implants made of artificial and naturalnon-livingmaterials; corneal shields being surgical implants and contact lenses made of artificial and naturalnon-livingmaterials; corneal implants made of artificial and naturalnon-livingmaterials; corneal implants for sight correction made of artificial and naturalnon-livingmaterials; intra-corneal implants made of artificial and naturalnon-livingmaterials; intra-ocular implants made of artificial and naturalnon-livingmaterials; ocular implants made of artificial and naturalnon-livingmaterials; medical implants made of artificial and naturalnon-livingmaterials; biodegradable implants for eyeskinheart applicationsmade of artificial and naturalnon-livingmaterials; prosthetic implants for eyeskinheart applicationsmade of artificial and naturalnon-livingmaterials; artificial implants for eyeskinheart applicationsmade of artificial and naturalnon-livingmaterials for delivery of cellsstem cellsdrugsgenesproteins

Publicações

Histórico de despachos e eventos da marca no USPTO.

38 publicações encontradas

NREP

NEW REPRESENTATIVE AT IB RECEIVED

07/03/2025

FINO

FINAL DECISION TRANSACTION PROCESSED BY IB

04/04/2022

FICS

FINAL DISPOSITION NOTICE SENT TO IB

15/03/2022

FIMP

FINAL DISPOSITION PROCESSED

14/03/2022

FICR

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

28/12/2021

R.PR

REGISTERED-PRINCIPAL REGISTER

28/09/2021

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

13/07/2021

PUBO

PUBLISHED FOR OPPOSITION

13/07/2021

GPNX

NOTIFICATION PROCESSED BY IB

11/07/2021

OPNS

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

23/06/2021

OP2R

NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB

23/06/2021

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

23/06/2021

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

04/06/2021

XAEC

EXAMINER'S AMENDMENT ENTERED

04/06/2021

GNEN

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

04/06/2021

GNEA

EXAMINERS AMENDMENT E-MAILED

04/06/2021

CNEA

EXAMINERS AMENDMENT -WRITTEN

04/06/2021

GNFN

NOTIFICATION OF FINAL REFUSAL EMAILED

09/01/2021

GNFR

FINAL REFUSAL E-MAILED

09/01/2021

CNFR

FINAL REFUSAL WRITTEN

09/01/2021

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

19/12/2020

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

18/12/2020

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

18/12/2020

CHAN

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

18/12/2020

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

18/12/2020

ECDR

TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS

18/12/2020

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

18/12/2020

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

18/12/2020

COAR

TEAS CHANGE OF OWNER ADDRESS RECEIVED

18/12/2020

RFNT

REFUSAL PROCESSED BY IB

01/08/2020

RFCS

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

14/07/2020

RFRR

REFUSAL PROCESSED BY MPU

14/07/2020

RFCR

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

09/06/2020

CNRT

NON-FINAL ACTION WRITTEN

08/06/2020

MAFR

APPLICATION FILING RECEIPT MAILED

02/06/2020

DOCK

ASSIGNED TO EXAMINER

29/05/2020

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

29/05/2020

REPR

SN ASSIGNED FOR SECT 66A APPL FROM IB

28/05/2020

Proteção contínua da sua marca

Seja avisado a cada novo depósito que ameace CORVISION ou a sua marca.

Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.